By Sabela OjeaPalisade Bio withdrew its Dec. 29 S-1 filing for a stock offering on Friday, and said it will seek stockholder approval for a potential reverse split. Shares of the biotechnology company surge 37% to 71 cents in after-hours trading. Write to Sabela Ojea at sabela.ojea@wsj.com

Source: Wall Street Journal January 27, 2024 19:43 UTC